R&D investment found 4% level of net sales.

Published: 1999-02-23 16:59:00

Updated: 1999-02-23 16:59:00

Domestic drug makers revealed their hot enthusiasm in developing new drugs amid expectation of the first birth of domestic new drug this year. Despite a difficult management environment under the IMF economic crisis they included the R&D of new drug discovery to their strategic management objecti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK